Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 76.17M | 97.49M | 100.52M | 95.36M | 84.26M | 84.26M |
Gross Profit | 76.17M | 97.49M | 100.52M | 95.36M | 84.26M | 84.26M |
EBITDA | 21.38M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 25.44M | 17.91M | 25.44M | 33.72M | 37.98M | 37.98M |
Balance Sheet | ||||||
Total Assets | 466.85M | 445.06M | 466.85M | 428.17M | 428.17M | 327.23M |
Cash, Cash Equivalents and Short-Term Investments | 1.00K | 5.22M | 1.00K | 3.14M | 3.14M | -417.00K |
Total Debt | 224.80M | 0.00 | 224.80M | 196.09M | 196.09M | 113.98M |
Total Liabilities | 232.68M | 206.98M | 232.68M | 203.29M | 203.29M | 120.48M |
Stockholders Equity | 234.16M | 238.08M | 234.16M | 224.88M | 224.88M | 206.75M |
Cash Flow | ||||||
Free Cash Flow | -711.00K | 64.27M | -711.00K | -63.59M | -63.59M | -2.47M |
Operating Cash Flow | -446.00K | 64.99M | -446.00K | -62.76M | -62.76M | -2.09M |
Investing Cash Flow | -189.00K | -685.00K | -189.00K | -660.00K | -660.00K | -284.00K |
Financing Cash Flow | -2.50M | -59.09M | -2.50M | 66.56M | 66.56M | 2.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | £456.78M | 6.37 | 14.70% | 3.97% | -7.52% | 50.23% | |
66 Neutral | £224.79M | ― | 5.25% | ― | ― | ||
64 Neutral | £5.53B | 9.22 | 9.73% | 4.99% | 9.49% | -16.43% | |
61 Neutral | £289.14M | ― | -16.30% | 9.29% | -3.77% | -147.20% | |
35 Underperform | £1.57M | ― | -200.00% | ― | -97.14% | 98.49% |